Pain relief from epidural in laparoscopic surgery

Evaluation of analgesic effects and hemodynamic response of epidural ropivacaine in laparoscopic abdominal surgeries.

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/12/016559

Enrollment

Registered

2018-12-07

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K928- Other specified diseases of the digestive system Health Condition 2: K928- Other specified diseases of the digestive system

Interventions

Intervention1: Thoracic epidural analgesia with 0.2 % ropivacaine intraoperatively and 0.1% postoperatively: Analgesia with epidural ropivacaine 0.2% intraoperatively 0.1% postoperatively Control Inte

Eligibility

Inclusion criteria

Inclusion criteria: Patients of ASA physical status I, II and III presenting for elective laparoscopic abdominal surgery

Exclusion criteria

Exclusion criteria: Contraindication for epidural anaesthesia, BMI > 35,severe CAD EF < 35%, COPD Class III and above, CKD class III

Design outcomes

Primary

Measure	Time frame
Analgesic effect of epidural ropivacaine in laparoscopic abdominal surgeryTimepoint: MAP more than 20 percent from baseline during surgery	—

Secondary

Measure	Time frame
1. Postoperative analgesia measured ny NRS and OPS 2. LOICU stay 3. Time to ambulation 4. Duration of catheterisationTimepoint: 6th hrly for 24 h postoperatively	—

Countries

India

Contacts

Public ContactDr Dipthi Jayadevan

Amrita Institute of Medical Sciences

lakshmi.k.238@gmail.com9496211333

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026